Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.

Pharmacogenomics - 1 Feb 2016

Agarwal Aniruddha, Ingham Sally A, Harkins Keegan A, Do Diana V, Nguyen Quan Dong

Abstract excerpt

Diabetic retinopathy (DR) and its complications such as diabetic macular edema continue to remain a major cause for legal blindness in the developed world. While the introduction of anti-tVEGF agents has significantly improved visual outcomes of patients with DR, unpredictable response, largely due to genetic polymorphisms, appears to be a challenge with this therapy. With advances in identification of various...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetic Retinopathy
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Genetic Therapy

Share to Genotype

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 26807609
DOI: 10.2217/pgs.15.173

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.PMID 26807609Read ↗

Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment.Semantic proximity Read ↗

Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized WorldSemantic proximity Read ↗

Advances in the Molecular Pathophysiology and Emerging Therapeutic Strategies for Diabetic RetinopathySemantic proximity Read ↗

A Guide to Genome-Wide Association Study Design for Diabetic Retinopathy.Semantic proximity Read ↗

Do Genomic Factors Play a Role in Diabetic Retinopathy?Semantic proximity Read ↗

Human Genetics of Diabetic Retinopathy: Current PerspectivesSemantic proximity Read ↗

Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and ProgressSemantic proximity Read ↗

Genotypes and Phenotypes: A Search for Influential Genes in Diabetic Retinopathy.Semantic proximity Read ↗

A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping.Semantic proximity Read ↗

[Diabetic retinopathy risk factors].Semantic proximity Read ↗

Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future DirectionsSemantic proximity Read ↗

Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune MechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.